9 completed, 2 active not recruiting, 1 not yet recruiting, 1 terminated. 13 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 13 | Completed 9, Active not recruiting 2, Not yet recruiting 1, Terminated 1 |
Follow Bladder Cancer: new trials by email Literature Review of Bladder Cancer trials Research Report on Bladder Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bladder Preservation or Cystectomy for MIBC Gemzar, Cisplatin, Adrucil - Muscle-Invasive Bladder Carcinoma, Bladder Cancer | Early Phase 1 | Active not recruiting | Dana-Farber Cancer Institute | 20 | 2026-09-02 | 2026-09-15 |
| Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer [64Cu]CM500, [68Ga]CM500, PET/MR - Bladder Cancer, Glioma | Early Phase 1 | Not yet recruiting | Lumina Pharmaceuticals Inc | 40 | 2026-09-01 | 2026-08-28 |
| Assessment of Safety, Tolerability, Radiation Dosimetry, Imaging Properties of 89Zr-girentuximab in Patients With NMIBC 89Zr-TLX250 - Bladder Cancer | Early Phase 1 | Completed | Institut Cancerologie de l'Ouest | 6 | 2021-12-15 | 2026-01-07 |
| A Clinical Study of Recombinant Oncolytic Adenovirus L-IFN Injection With Multiple Administration Routes in Relapsed/Refractory Solid Tumors Recombinant L-IFN adenovirus injection - Head and Neck Cancer, Melanoma | Early Phase 1 | Completed | Shanghai Fengxian District Central Hospital | 25 | 2021-11-30 | 2026-11-16 |
| 18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy 18F-fluciclovine, PET/CT - Bladder Cancer, Urothelial Carcinoma | Early Phase 1 | Completed | Brigham and Women's Hospital | 16 | 2020-02-26 | 2026-06-24 |
| (CLONEVO): Cell cycLe inhbitiON to Target the EVolution of UrOthelial Cancer Abemaciclib - Bladder Cancer | Early Phase 1 | Active not recruiting | Weill Medical College of Cornell University | 20 | 2019-02-05 | 2026-10-26 |
| A Superiority Trial to Compare Re-resection of High-grade T1 Bladder Urothelial Carcinoma to no Re-resection for Improving Progression Free Survival re-TURBT, 6 weeks BCG instillation - Bladder Cancer, Bladder Urothelial Carcinoma | Early Phase 1 | Terminated | University Health Network, Toronto | 2 | 2017-11-16 | 2022-04-20 |
| A Study of Rapamycin Combined With Intravesical BCG in Patients With Non-muscle Invasive Bladder Cancer Sirolimus - Bladder Cancer | Early Phase 1 | Completed | The University of Texas Health Science Center at San Antonio | 33 | 2016-06-01 | 2021-03-19 |
| PRIME: Pilot Study Evaluating Percutaneous Vaccination of BCG for Bladder Cancer Bacillus Calmette-Guerin (BCG) - Bladder Cancer | Early Phase 1 | Completed | The University of Texas Health Science Center at San Antonio | 25 | 2013-10-01 | 2017-01-25 |
| Impact Advanced Recovery® for Radical Cystectomy (RC) Patients: a Pilot Study Boost Plus®, Impact Advanced Recovery® - Bladder Cancer, Radical Cystectomy | Early Phase 1 | Completed | Jill Hamilton-Reeves, PhD RD LD | 30 | 2013-07-01 | 2026-04-15 |
| BLADDER CANCER SCREENING AMONG DIABETIC PATIENTS metformin - Bladder Cancer, Diabetes | Early Phase 1 | Completed | UFUOMA MILLER FAKPOR | 150 | 2013-06-01 | 2015-07-22 |
| Impact of Valproate on Angiogenesis and Histone Deacetylation in Bladder Cancer Valproic Acid - Hematuria, Bladder Cancer | Early Phase 1 | Completed | State University of New York - Upstate Medical University | 43 | 2011-12-01 | 2021-10-22 |
| Study of BCG + Aminophylline Toxicity When Used in the Treatment of Bladder Cancer aminophylline - Bladder Cancer | Early Phase 1 | Completed | University of Virginia | 3 | 2010-07-01 | 2014-04-14 |
Urinary Bladder Neoplasms (13) · Carcinoma, Transitional Cell (3) · Breast Neoplasms (2) · Lung Neoplasms (2) · Ovarian Neoplasms (2) · Carcinoma, Non-Small-Cell Lung (1) · Colorectal Neoplasms (1) · Diabetes Mellitus (1) · Esophageal Neoplasms (1) · Glioblastoma (1) · Glioma (1) · Head and Neck Neoplasms (1) · Hematuria (1) · Kidney Neoplasms (1) · Liver Neoplasms (1)
Female Urogenital Diseases (13) · Female Urogenital Diseases and Pregnancy Complications (13) · Male Urogenital Diseases (13) · Neoplasms by Site (13) · Urinary Bladder Diseases (13) · Urogenital Diseases (13) · Urogenital Neoplasms (13) · Urologic Diseases (13) · Urologic Neoplasms (13) · Neoplasms (12) · Neoplasms by Histologic Type (6) · Neoplasms, Glandular and Epithelial (5) · Carcinoma (4) · Endocrine System Diseases (3) · Adnexal Diseases (2)
Positron Emission Tomography Computed Tomography (2) · Aminophylline (1) · BCG Vaccine (1) · Blood Specimen Collection (1) · Cisplatin (1) · Cystectomy (1) · Fluorouracil (1) · Gemcitabine (1) · Metformin (1) · Mitomycin (1) · Oncolytic Virotherapy (1) · Sirolimus (1) · Valproic Acid (1) · abemaciclib (1) · fluciclovine F-18 (1)
The University of Texas Health Science Center at San Antonio (2) · Brigham and Women's Hospital (1) · Dana-Farber Cancer Institute (1) · Institut Cancerologie de l'Ouest (1) · Jill Hamilton-Reeves, PhD RD LD (1) · Lumina Pharmaceuticals Inc (1) · Shanghai Fengxian District Central Hospital (1) · State University of New York - Upstate Medical University (1) · UFUOMA MILLER FAKPOR (1) · University Health Network, Toronto (1) · University of Virginia (1) · Weill Medical College of Cornell University (1)
United States (9) · Canada (1) · China (1) · France (1) · Ghana (1)
Bishoy Faltas, MD (1) · Charlene Mantia, MD (1) · Feng Liu, PhD (1) · Girish Kulkarni, MD PhD FRCSC (1) · Heather Jacene, MD (1) · Jill Hamilton-Reeves, PhD, RD, LD (1) · Oleg Shapiro, MD (1) · Robert S Svatek, MD (1) · Robert Svatek, MD (1) · Tracy L Krupski, M.D. (1)
PMID 26654125, PMID 33653802, PMID 38719544
R44CA275590 (1)